Back to Authors

Parvin, Curtis A.

Mayo Clinic

Bio-Rad (United States)

Citations 2

Assessing Quality Control Strategies for HbA1c Measurements From a Patient Risk Perspective
Parvin, Curtis A., Baumann, N, Baumann, Nikola A

Journal of Diabetes Science and Technology | February 16, 2018 | Volume: 12 | Issue: 4 | Pages: 786-791

10.1177/1932296818758768 Get It

Background: Current laboratory risk management principles emphasize the importance of assessing laboratory quality control (QC) practices in terms of the risk of patient harm. Limited practical guidance or examples on how to do this are available. Methods: The patient risk model described in a published laboratory risk management guideline was combined with a recently reported approach to computing the predicted probability of patient harm to produce a risk management index (RMI) that compares the predicted probability of patient harm for a QC strategy to the acceptable probability of patient harm based on the expected severity of harm caused by an erroneously reported patient result. Results: Measurement procedure capability and quality control performance for two instruments measuring HbA1c in a laboratory were assessed by computing the RMI for each instrument individually and for the laboratory as a whole. Conclusions: This assessment provides a concrete example of how laboratory QC practices can be directly correlated to the risk of patient harm from erroneously reported patient results.
Validation of the 99th Percentile Cutoff Independent of Assay Imprecision (CV) for Cardiac Troponin Monitoring for Ruling Out Myocardial Infarction
Apple, Fred S. , Parvin, Curtis A., Buechler, Kenneth F., Christenson, Robert H. , Wu, Alan H.B. , Jaffe, Allan S. , Jaffe, Allan S.

Clinical Chemistry | October 26, 2005 | Volume: 51 | Issue: 11 | Pages: 2198-2200

10.1373/clinchem.2005.052886 Get It